The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Nine states have been identified as being affected by the chocolate recall, but the products were available online so others ...
A major chocolate recall has been upgraded to the highest possible risk level.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.